| P2093 | author name string | Shu Wang | |
| | Liang Xu | |
| | Jie Pan | |
| | Danni Chen | |
| | Weimin Fan | |
| | Peifen Fu | |
| | Wengong Si | |
| | Mingjie Xu | |
| | Huilin Zheng | |
| | Jiaying Shen | |
| | Chengyong Du | |
| | Minya Yao | |
| P2860 | cites work | Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium | Q24318429 |
| | Histone deacetylase inhibitors: Potential in cancer therapy | Q24649025 |
| | Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells | Q24654966 |
| | MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia | Q26766288 |
| | Global cancer statistics, 2012 | Q27860501 |
| | Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 |
| | edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 |
| | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 |
| | miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1 | Q28283590 |
| | Cancer epigenetics: from mechanism to therapy | Q29614799 |
| | Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway | Q33825014 |
| | NK cell-based immunotherapy for malignant diseases | Q33827433 |
| | Upregulation of MICA on high-grade invasive operable breast carcinoma | Q34111707 |
| | NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study | Q34132372 |
| | Anti-tumor mechanisms of valproate: a novel role for an old drug | Q34147644 |
| | MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma | Q34241771 |
| | miRNAs and cancer: an epigenetics view | Q34286618 |
| | Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression | Q34339775 |
| | MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape | Q34365811 |
| | The miR-17 family links p63 protein to MAPK signaling to promote the onset of human keratinocyte differentiation | Q34430001 |
| | NKG2D ligands: key targets of the immune response. | Q34792486 |
| | MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer | Q34995302 |
| | Innate immune recognition of cancer | Q35549322 |
| | Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma. | Q35677697 |
| | Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer | Q35782978 |
| | An overview of microRNAs | Q35858483 |
| | Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation | Q36044823 |
| | Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells | Q36157436 |
| | NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer | Q36399548 |
| | Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance. | Q36446484 |
| | Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma | Q36520715 |
| | MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer | Q38095501 |
| | Inhibition of HDAC increases the senescence induced by natural polyphenols in glioma cells | Q38970906 |
| | Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells. | Q39107568 |
| | MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells | Q39292548 |
| | DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases | Q39763578 |
| | Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. | Q39910403 |
| | Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. | Q39954301 |
| | Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. | Q40134133 |
| | BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia | Q40296130 |
| | NKG2D ligands are expressed on stressed human airway epithelial cells | Q40317527 |
| | Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells | Q40569022 |
| | Natural killer resistance of a drug-resistant leukemia cell line, mediated by up-regulation of HLA class I expression. | Q40648100 |
| | Distinct mechanisms of tumor resistance to NK killing: of mice and men. | Q41097352 |
| | Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer | Q44124507 |
| | Nfl gene inactivation in acute myeloid leukemia cells confers cytarabine resistance through MAPK and mTOR pathways | Q46819258 |
| | Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis | Q47347848 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | edgeR | Q113334690 |
| P433 | issue | 4 | |
| P304 | page(s) | e2740 | |
| P577 | publication date | 2017-04-06 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer | |
| P478 | volume | 8 | |